Greenberg Traurig, LLP represented Hangzhou Zhongmei Huadong Pharmaceutical and Huadong Medicine Co. on the matter. Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage biopharmaceutical company focused...
Hangzhou Zhongmei Huadong Pharmaceutical Co..’s Licensing Agreement with Arcutis Biotherapeutic
Hangzhou Zhongmei Huadong Pharmaceutical’s Licensing Agreement with MC2 Therapeutics
Greenberg Traurig, LLP represented Hangzhou Zhongmei Huadong Pharmaceutical and Huadong Medicine Co. on the matter. Hangzhou Zhongmei Huadong Pharmaceutical, a subsidiary of Huadong Medicine, negotiated a licensing agreement...
Corbel Capital Partners’ Investment to Create Premier Plastic Surgery Partners
Sheppard Mullin represented Corbel Capital Partners, while Greenberg Traurig advised Premier Plastic Surgery Partners on the transaction. Premier Plastic Surgery Partners, LLC announced the formation of...
HelpSystems’ Acquisition of Tripwire
Fredrikson & Byron represented HelpSystems in the transaction while Greenberg Traurig advised Tripwire Interactive. HelpSystems, a software company focused on helping organizations secure and automate their...
Huadong Medicine’s Collaboration with Kiniksa Pharmaceuticals
Greenberg Traurig represented Huadong Medicine on the deal, while Ropes & Gray advised Kiniksa Pharmaceuticals. Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., a wholly owned subsidiary of...